Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles

Zhouyu Zhu; Tao Yu; Ying Chai

doi:10.18632/oncotarget.13046

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Case Reports:

This article has an addendum. Addendum in: Oncotarget. 2022; 13:1271-1271.

Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles

Zhouyu Zhu, Tao Yu and Ying Chai _

PDF | HTML | How to cite

Oncotarget. 2016; 7:81969-81971. https://doi.org/10.18632/oncotarget.13046

Metrics: PDF 1811 views | HTML 2187 views | ?

Abstract

Zhouyu Zhu1, Tao Yu1 and Ying Chai1

1 Department of Thoracic Surgery, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

Correspondence to:

Ying Chai, email:

Keywords: multiple primary lung cancer, EGFR, PTEN, gefitinib

Received: August 15, 2016 Accepted: October 28, 2016 Published: November 03, 2016

Abstract

We present a case of multiple primary lung cancer(MPLC) displaying heterogeneous EGFR and PTEN molecular profiles. Considering the physical condition of patients, the patient underwent surgical resection of the right lung lesion displaying gefitinib-insensitive and continued gefitinib treatment for the gefitinib-sensitive lesions in the left lung. As far as we know, this is the first report documenting a case of an integrated therapy strategy using surgical resection with gefitinib treatment for MPLC displaying different EGFR and PTEN molecular profiles. The patient has been in progression free survival up to now. Our experience could provide a treatment strategy for patients with similar disease.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 13046

Publication Alerts

Post-Publication Promotion

Publication Discount

Case Reports:

Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles

Abstract